Collectively, by performing conventional molecular methods, our results revealed that treatment with TubA significantly ameliorates osteoarthritis and inhibits the level of HDAC6 in chondrocytes, which results in activation of autophagy, cell survival and reduction of ECM degradation. The gene discussed is HDAC6; the disease is osteoarthritis.